New study advances cancer precision therapies by identifying patients who benefit from Bexmarilimab treatment 20 May 2025
Funding from the Finnish Research Impact Foundation for Professor Cecilia Söderberg-Nauclér 4 December 2024
Cancer therapy bexmarilimab awakens immune cells to attack tumours that have avoided the detection of the immune system 7 December 2023
Unlocking the secrets of cell behaviour on soft substrates: A paradigm shift in mechanobiology 18 October 2023
